Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1988 Feb;81(2):596–600. doi: 10.1172/JCI113358

Synthetic human parathyroid hormone-like protein stimulates bone resorption and causes hypercalcemia in rats.

A F Stewart 1, M Mangin 1, T Wu 1, D Goumas 1, K L Insogna 1, W J Burtis 1, A E Broadus 1
PMCID: PMC329608  PMID: 3339131

Abstract

Parathyroid hormone-like adenylate cyclase-stimulating proteins (hACSPs) have been implicated as one of the calcemic, bone-resorbing agents in patients with humoral hypercalcemia of malignancy. We report the synthesis of an amino-terminal hACSP fragment, Tyr36 hACSP (1-36) amide. The synthetic hACSP is a potent agonist of renal membrane adenylate cyclase (Km, 1.7 X 10(-10)) and of bone cell adenylate cyclase (Km 1 X 10(-9)M). It is a potent bone-resorbing agent in vitro, stimulating 45Ca release from fetal rat long bones at a concentration of 10(-9) M. When infused via osmotic minipumps into rats, it is also a potent calcemic factor in vivo, inducing a rise in serum calcium from (mean +/- SD) 10.6 +/- 0.6 to 19.7 +/- 3.2 mg/dl when infused at 1.4 micrograms/h and from 9.9 +/- 0.7 to 11.4 +/- 1.2 mg/dl when infused at 0.14 micrograms/h. These findings indicate that biologically active hACSP fragments can be synthesized. One such synthetic peptide possesses the in vitro and in vivo bioactivities demonstrated in native, tumor-derived hACSPs. It is also a potent calcemic, bone-resorbing agent.

Full text

PDF
600

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bertolini D. R., Nedwin G. E., Bringman T. S., Smith D. D., Mundy G. R. Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. Nature. 1986 Feb 6;319(6053):516–518. doi: 10.1038/319516a0. [DOI] [PubMed] [Google Scholar]
  2. Burtis W. J., Wu T., Bunch C., Wysolmerski J. J., Insogna K. L., Weir E. C., Broadus A. E., Stewart A. F. Identification of a novel 17,000-dalton parathyroid hormone-like adenylate cyclase-stimulating protein from a tumor associated with humoral hypercalcemia of malignancy. J Biol Chem. 1987 May 25;262(15):7151–7156. [PubMed] [Google Scholar]
  3. Dewhirst F. E., Stashenko P. P., Mole J. E., Tsurumachi T. Purification and partial sequence of human osteoclast-activating factor: identity with interleukin 1 beta. J Immunol. 1985 Oct;135(4):2562–2568. [PubMed] [Google Scholar]
  4. Doppelt S. H., Neer R. M., Nussbaum S. R., Federico P., Potts J. T., Jr, Rosenblatt M. Inhibition of the in vivo parathyroid hormone-mediated calcemic response in rats by a synthetic hormone antagonist. Proc Natl Acad Sci U S A. 1986 Oct;83(19):7557–7560. doi: 10.1073/pnas.83.19.7557. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Habener J. F., Rosenblatt M., Potts J. T., Jr Parathyroid hormone: biochemical aspects of biosynthesis, secretion, action, and metabolism. Physiol Rev. 1984 Jul;64(3):985–1053. doi: 10.1152/physrev.1984.64.3.985. [DOI] [PubMed] [Google Scholar]
  6. Ibbotson K. J., D'Souza S. M., Smith D. D., Carpenter G., Mundy G. R. EGF receptor antiserum inhibits bone resorbing activity produced by a rat Leydig cell tumor associated with the humoral hypercalcemia of malignancy. Endocrinology. 1985 Jan;116(1):469–471. doi: 10.1210/endo-116-1-469. [DOI] [PubMed] [Google Scholar]
  7. Ibrahim M. M., Forte L. R., Thomas M. L. Maintenance of normocalcemia by continuous infusion of the synthetic bovine parathyroid hormone (1-34) in parathyroidectomized rats. Calcif Tissue Int. 1982;34(6):553–557. doi: 10.1007/BF02411303. [DOI] [PubMed] [Google Scholar]
  8. Insogna K. L., Weir E. C., Wu T. L., Stewart A. F., Broadus A. E., Burtis W. J., Centrella M. Co-purification of transforming growth factor beta-like activity with PTH-like and bone-resorbing activities from a tumor associated with humoral hypercalcemia of malignancy. Endocrinology. 1987 May;120(5):2183–2185. doi: 10.1210/endo-120-5-2183. [DOI] [PubMed] [Google Scholar]
  9. Klein R. F., Strewler G. J., Leung S. C., Nissenson R. A. Parathyroid hormone-like adenylate cyclase-stimulating activity from a human carcinoma is associated with bone-resorbing activity. Endocrinology. 1987 Feb;120(2):504–511. doi: 10.1210/endo-120-2-504. [DOI] [PubMed] [Google Scholar]
  10. Merendino J. J., Jr, Insogna K. L., Milstone L. M., Broadus A. E., Stewart A. F. A parathyroid hormone-like protein from cultured human keratinocytes. Science. 1986 Jan 24;231(4736):388–390. doi: 10.1126/science.2417317. [DOI] [PubMed] [Google Scholar]
  11. Moseley J. M., Kubota M., Diefenbach-Jagger H., Wettenhall R. E., Kemp B. E., Suva L. J., Rodda C. P., Ebeling P. R., Hudson P. J., Zajac J. D. Parathyroid hormone-related protein purified from a human lung cancer cell line. Proc Natl Acad Sci U S A. 1987 Jul;84(14):5048–5052. doi: 10.1073/pnas.84.14.5048. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Nissenson R. A., Strewler G. J., Williams R. D., Leung S. C. Activation of the parathyroid hormone receptor-adenylate cyclase system in osteosarcoma cells by a human renal carcinoma factor. Cancer Res. 1985 Nov;45(11 Pt 1):5358–5363. [PubMed] [Google Scholar]
  13. RAISZ L. G. BONE RESORPTION IN TISSUE CULTURE. FACTORS INFLUENCING THE RESPONSE TO PARATHYROID HORMONE. J Clin Invest. 1965 Jan;44:103–116. doi: 10.1172/JCI105117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Rabbani S. A., Mitchell J., Roy D. R., Kremer R., Bennett H. P., Goltzman D. Purification of peptides with parathyroid hormone-like bioactivity from human and rat malignancies associated with hypercalcemia. Endocrinology. 1986 Mar;118(3):1200–1210. doi: 10.1210/endo-118-3-1200. [DOI] [PubMed] [Google Scholar]
  15. Ralston S. H., Fogelman I., Gardner M. D., Dryburgh F. J., Cowan R. A., Boyle I. T. Hypercalcaemia of malignancy: evidence for a nonparathyroid humoral agent with an effect on renal tubular handling of calcium. Clin Sci (Lond) 1984 Feb;66(2):187–191. doi: 10.1042/cs0660187. [DOI] [PubMed] [Google Scholar]
  16. Rodan S. B., Insogna K. L., Vignery A. M., Stewart A. F., Broadus A. E., D'Souza S. M., Bertolini D. R., Mundy G. R., Rodan G. A. Factors associated with humoral hypercalcemia of malignancy stimulate adenylate cyclase in osteoblastic cells. J Clin Invest. 1983 Oct;72(4):1511–1515. doi: 10.1172/JCI111108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Rosenblatt M., Callahan E. N., Mahaffey J. E., Pont A., Potts J. T., Jr Parathyroid hormone inhibitors. Design, synthesis, and biologic evaluation of hormone analogues. J Biol Chem. 1977 Aug 25;252(16):5847–5851. [PubMed] [Google Scholar]
  18. Sharp C. F., Jr, Rude R. K., Terry R., Singer F. R. Abnormal bone and parathyroid histology in carcinoma patients with pseudohyperparathyroidism. Cancer. 1982 Apr 1;49(7):1449–1455. doi: 10.1002/1097-0142(19820401)49:7<1449::aid-cncr2820490723>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  19. Silve C., Santora A., Spiegel A. A factor produced by cultured rat Leydig tumor (Rice 500) cells associated with humoral hypercalcemia stimulates adenosine 3',5'-monophosphate production via the parathyroid hormone receptor in human skin fibroblasts. J Clin Endocrinol Metab. 1985 Jun;60(6):1144–1147. doi: 10.1210/jcem-60-6-1144. [DOI] [PubMed] [Google Scholar]
  20. Stern P. H., Krieger N. S., Nissenson R. A., Williams R. D., Winkler M. E., Derynck R., Strewler G. J. Human transforming growth factor-alpha stimulates bone resorption in vitro. J Clin Invest. 1985 Nov;76(5):2016–2019. doi: 10.1172/JCI112202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Stewart A. F., Burtis W. J., Wu T., Goumas D., Broadus A. E. Two forms of parathyroid hormone-like adenylate cyclase-stimulating protein derived from tumors associated with humoral hypercalcemia of malignancy. J Bone Miner Res. 1987 Dec;2(6):587–593. doi: 10.1002/jbmr.5650020616. [DOI] [PubMed] [Google Scholar]
  22. Stewart A. F., Horst R., Deftos L. J., Cadman E. C., Lang R., Broadus A. E. Biochemical evaluation of patients with cancer-associated hypercalcemia: evidence for humoral and nonhumoral groups. N Engl J Med. 1980 Dec 11;303(24):1377–1383. doi: 10.1056/NEJM198012113032401. [DOI] [PubMed] [Google Scholar]
  23. Stewart A. F., Insogna K. L., Goltzman D., Broadus A. E. Identification of adenylate cyclase-stimulating activity and cytochemical glucose-6-phosphate dehydrogenase-stimulating activity in extracts of tumors from patients with humoral hypercalcemia of malignancy. Proc Natl Acad Sci U S A. 1983 Mar;80(5):1454–1458. doi: 10.1073/pnas.80.5.1454. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Stewart A. F., Vignery A., Silverglate A., Ravin N. D., LiVolsi V., Broadus A. E., Baron R. Quantitative bone histomorphometry in humoral hypercalcemia of malignancy: uncoupling of bone cell activity. J Clin Endocrinol Metab. 1982 Aug;55(2):219–227. doi: 10.1210/jcem-55-2-219. [DOI] [PubMed] [Google Scholar]
  25. Stewart A. F., Wu T., Burtis W. J., Weir E. C., Broadus A. E., Insogna K. L. The relative potency of a human tumor-derived PTH-like adenylate cyclase-stimulating preparation in three bioassays. J Bone Miner Res. 1987 Feb;2(1):37–43. doi: 10.1002/jbmr.5650020107. [DOI] [PubMed] [Google Scholar]
  26. Stewart A. F., Wu T., Goumas D., Burtis W. J., Broadus A. E. N-terminal amino acid sequence of two novel tumor-derived adenylate cyclase-stimulating proteins: identification of parathyroid hormone-like and parathyroid hormone-unlike domains. Biochem Biophys Res Commun. 1987 Jul 31;146(2):672–678. doi: 10.1016/0006-291x(87)90581-x. [DOI] [PubMed] [Google Scholar]
  27. Strewler G. J., Williams R. D., Nissenson R. A. Human renal carcinoma cells produce hypercalcemia in the nude mouse and a novel protein recognized by parathyroid hormone receptors. J Clin Invest. 1983 Mar;71(3):769–774. doi: 10.1172/JCI110825. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Tashjian A. H., Jr, Voelkel E. F., Lazzaro M., Goad D., Bosma T., Levine L. Tumor necrosis factor-alpha (cachectin) stimulates bone resorption in mouse calvaria via a prostaglandin-mediated mechanism. Endocrinology. 1987 May;120(5):2029–2036. doi: 10.1210/endo-120-5-2029. [DOI] [PubMed] [Google Scholar]
  29. Wu T. L., Insogna K. L., Hough L. M., Milstone L., Stewart A. F. Skin-derived fibroblasts respond to human parathyroid hormone-like adenylate cyclase-stimulating proteins. J Clin Endocrinol Metab. 1987 Jul;65(1):105–109. doi: 10.1210/jcem-65-1-105. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES